Metropolitan Life Insurance Company (MetLife)’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,059
| Closed | -$67.5K | – | 2399 |
|
|
2022
Q2 | $67.5K | Sell |
2,059
-342
| -14% | -$10.8K | ﹤0.01% | 1309 |
|
|
2022
Q1 | $63.1K | Sell |
2,401
-8,377
| -78% | -$204K | ﹤0.01% | 1461 |
|
|
2021
Q4 | $256K | Hold |
10,778
| – | – | ﹤0.01% | 1847 |
|
|
2021
Q3 | $270K | Hold |
10,778
| – | – | ﹤0.01% | 1859 |
|
|
2021
Q2 | $280K | Buy |
10,778
+622
| +6% | +$16.9K | ﹤0.01% | 1909 |
|
|
2021
Q1 | $260K | Sell |
10,156
-726
| -7% | -$18.6K | ﹤0.01% | 1835 |
|
|
2020
Q4 | $218K | Hold |
10,882
| – | – | ﹤0.01% | 1882 |
|
|
2020
Q3 | $186K | Hold |
10,882
| – | – | ﹤0.01% | 1811 |
|
|
2020
Q2 | $237K | Hold |
10,882
| – | – | ﹤0.01% | 1689 |
|
|
2020
Q1 | $252K | Hold |
10,882
| – | – | 0.01% | 1458 |
|
|
2019
Q4 | $359K | Hold |
10,882
| – | – | 0.01% | 1533 |
|
|
2019
Q3 | $346K | Buy |
10,882
+440
| +4% | +$12.8K | 0.01% | 1522 |
|
|
2019
Q2 | $268K | Hold |
10,442
| – | – | ﹤0.01% | 1693 |
|
|
2019
Q1 | $265K | Hold |
10,442
| – | – | ﹤0.01% | 1709 |
|
|
2018
Q4 | $355K | Hold |
10,442
| – | – | 0.01% | 1433 |
|
|
2018
Q3 | $372K | Hold |
10,442
| – | – | 0.01% | 1579 |
|
|
2018
Q2 | $360K | Hold |
10,442
| – | – | 0.01% | 1543 |
|
|
2018
Q1 | $351K | Buy |
10,442
+569
| +6% | +$18K | 0.01% | 1502 |
|
|
2017
Q4 | $377K | Sell |
9,873
-13,864
| -58% | -$553K | 0.01% | 1474 |
|
|
2017
Q3 | $890K | Hold |
23,737
| – | – | 0.01% | 1321 |
|
|
2017
Q2 | $885K | Hold |
23,737
| – | – | 0.01% | 1318 |
|
|
2017
Q1 | $932K | Hold |
23,737
| – | – | 0.01% | 1269 |
|
|
2016
Q4 | $826K | Buy |
23,737
+13
| +0.1% | +$510 | 0.01% | 1402 |
|
|
2016
Q3 | $932K | Sell |
23,724
-1,094
| -4% | -$43.6K | 0.01% | 1319 |
|
|
2016
Q2 | $938K | Hold |
24,818
| – | – | 0.01% | 1293 |
|
|
2016
Q1 | $954K | Buy |
24,818
+1,038
| +4% | +$38.7K | 0.01% | 1206 |
|
|
2015
Q4 | $1.14M | Sell |
23,780
-563
| -2% | -$26.1K | 0.01% | 1120 |
|
|
2015
Q3 | $960K | Hold |
24,343
| – | – | 0.01% | 1209 |
|
|
2015
Q2 | $1.04M | Sell |
24,343
-1,644
| -6% | -$65.5K | 0.01% | 1260 |
|
|
2015
Q1 | $1.03M | Hold |
25,987
| – | – | 0.01% | 1178 |
|
|
2014
Q4 | $937K | Hold |
25,987
| – | – | 0.01% | 1357 |
|
|
2014
Q3 | $767K | Hold |
25,987
| – | – | 0.01% | 1445 |
|
|
2014
Q2 | $653K | Buy |
25,987
+1,127
| +5% | +$27.9K | ﹤0.01% | 1638 |
|
|
2014
Q1 | $641K | Sell |
24,860
-375
| -1% | -$9.45K | ﹤0.01% | 1630 |
|
|
2013
Q4 | $568K | Hold |
25,235
| – | – | ﹤0.01% | 1723 |
|
|
2013
Q3 | $358K | Hold |
25,235
| – | – | ﹤0.01% | 1982 |
|
|
2013
Q2 | $344K | Buy |
+25,235
| New | +$344K | ﹤0.01% | 1944 |
|
Other funds holding NTUS
Metropolitan Life Insurance Company (MetLife)'s NTUS Position: Q3 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 2,059 shares — an estimated $67.5K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $1.14M in Q4 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,059 Natus Medical Inc shares in Q3 2022, an estimated $67.5K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Natus Medical Inc position peaked at $1.14M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.